Author

Noriyuki Kasahara

University of California, San FranciscoORCID 0000-0002-6069-9082Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

Megan L. MontoyaiD· 2 shared Pavlina ChuntovaiD· 2 shared S. A. CollinsiD· 2 shared Akane YamamichiiD· 1 shared Alexander F. HaddadiD· 1 shared Atul SahaiD· 1 shared Elaina J. WangiD· 1 shared Eric J. ChalifiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Megan L. MontoyaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Non-lytic replicating viral delivery of an IL15 superagonist enhances antitumor immunity and extends survival in glioblastoma

Alexander F. Haddad, Atul Saha, Sara Collins, Isabella Lovalvo, Sabraj A. Gill, Megan L. Montoya, Poojan D. Shukla, Jinpyo Hong, Elaina J. Wang, Pavlina Chuntova, Meeki Lad, Robert Osorio, Jia‐Shu Chen, Melissa Sathavipat, Saket Jain, , Manish K. Aghi

This paper demonstrates that a viral vector delivering an IL15 superagonist enhances antitumor immunity and extends survival in glioblastoma models.

Nature Communications · May 19, 2026Peer-reviewedCancer Biology

IRF8-driven reprogramming of the immune microenvironment enhances anti-tumor adaptive immunity and reduces immunosuppression in murine glioblastoma

Megan Montoya, S. A. Collins, Pavlina Chuntova, Trishna S. Patel, Takahide Nejo, Akane Yamamichi, Noriyuki Kasahara, Hideho Okada

This study shows that delivering IRF8 via retroviral vector reprograms myeloid cells in glioblastoma, enhancing anti-tumor immunity and reducing immunosuppression.

Neuro-Oncology · Aug 8, 2024Peer-reviewedImmunology